Published in Ann Thorac Surg on December 01, 1981
A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke. Nanomedicine (Lond) (2011) 0.90
Current status of erythrocyte substitutes. Can Med Assoc J (1983) 0.79
Regional distribution of diffusible tracers and carbonized microspheres in the left ventricle of isolated dog hearts. Circ Res (1973) 2.82
Fibrin glue: an effective hemostatic agent for nonsuturable intraoperative bleeding. Ann Thorac Surg (1984) 2.07
Transcoronary intravascular transport functions obtained via a stable deconvolution technique. Ann Biomed Eng (1976) 1.50
Tranexamic acid significantly reduces blood loss associated with coronary revascularization. Ann Thorac Surg (1995) 1.44
Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation (1999) 1.43
Postischemic deterioration of sarcoplasmic reticulum: warm versus cold blood cardioplegia. Ann Thorac Surg (1993) 1.39
Protective role of intracoronary fatty acid binding protein in ischemic and reperfused myocardium. Circ Res (1990) 1.39
Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun (1987) 1.29
Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol (2001) 1.29
Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res (1999) 1.28
Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res (2000) 1.24
Mediastinitis following open-heart surgery. Review of two years' experience. Arch Surg (1973) 1.19
Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Mol Cell Cardiol (1996) 1.17
Postpneumonectomy esophageal fistula: successful one-stage repair. J Thorac Cardiovasc Surg (1970) 1.16
Esophagogastrostomy. Analysis of 55 cases. J Thorac Cardiovasc Surg (1975) 1.15
Myocardial protection with red wine extract. J Cardiovasc Pharmacol (2000) 1.14
Epicardial activation of the intact human heart without conduction defect. Circulation (1979) 1.13
The long-term influence of coronary bypass grafts on myocardial infarction and survival. Ann Surg (1974) 1.13
Aneurysm of aberrant right subclavian artery. Rare cause of superior mediastinal tumor. N Y State J Med (1973) 1.10
Thoracic aortic dissection following cannulation for perfusion. Ann Thorac Surg (1974) 1.10
Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. Cardiovasc Res (1993) 1.05
Phrenic nerve paresis associated with the use of iced slush and the cooling jacket for topical hypothermia. J Thorac Cardiovasc Surg (1985) 1.02
Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation (1997) 1.00
Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am J Physiol (1986) 0.98
Risk of dysphagia after transesophageal echocardiography during cardiac operations. Ann Thorac Surg (2000) 0.97
The 'primeless pump': a novel technique for intraoperative blood conservation. Cardiovasc Surg (1999) 0.95
Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res (1995) 0.95
Oxygen free radical signaling in ischemic preconditioning. Ann N Y Acad Sci (1999) 0.95
The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res (1996) 0.94
Experience with open mitral commissurotomy in 100 consecutive patients. Surgery (1974) 0.94
Hyperosomolar coma in surgical patients: an latrogenic disease of increasing incidence. Ann Surg (1973) 0.94
Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation (1993) 0.92
Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am J Physiol (1995) 0.91
L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg (1995) 0.91
Complications of ventriculoatrial shunting for hydrocephalus requiring cardiac operation. Ann Thorac Surg (1969) 0.90
Transatrial repair of postinfarction posterior ventricular septal defect. Ann Thorac Surg (1987) 0.90
Coronary artery bypass with freeze-preserved saphenous vein allografts. J Thorac Cardiovasc Surg (1976) 0.90
Nitric oxide/carbon monoxide. A molecular switch for myocardial preservation during ischemia. Circulation (1996) 0.90
Coordinated role of vasoactive intestinal peptide and nitric oxide in cardioprotection. Ann N Y Acad Sci (1998) 0.89
Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch Trial. Circulation (2000) 0.89
Blood conservation for myocardial revascularization. Is it cost effective? J Thorac Cardiovasc Surg (1987) 0.89
Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures. J Thorac Cardiovasc Surg (1983) 0.89
Pathophysiology of superoxide radical as potential mediator of reperfusion injury in pig heart. Basic Res Cardiol (1986) 0.88
Safety of prolonged ischemic arrest using hypothermic cardioplegia. J Thorac Cardiovasc Surg (1980) 0.88
Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Circulation (2000) 0.88
Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem (1998) 0.88
Nitric oxide--a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol Cell Biochem (1996) 0.88
Use of extrafascially harvested radial artery for coronary artery revascularization: technical considerations. J Card Surg (2000) 0.88
Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers. J Mol Cell Cardiol (1991) 0.87
Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. Control of its production by a phospholipase inhibitor or free radical scavengers. J Mol Cell Cardiol (1986) 0.87
Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg (1995) 0.87
Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. Circulation (1993) 0.87
Estimation of the extent of lipid peroxidation in the ischemic and reperfused heart by monitoring lipid metabolic products with the aid of high-performance liquid chromatography. J Chromatogr (1993) 0.86
Effects of free radicals on the fluidity of myocardial membranes. Free Radic Res Commun (1989) 0.86
Traumatic ventricular septal defect following closed-chest massage: a new approach to closure. Ann Thorac Surg (1984) 0.86
Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J Pharmacol Exp Ther (1993) 0.86
Nonthrombogenic aortic and vena caval bypass using heparin-coated tubes. Am J Surg (1974) 0.85
Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. J Pharmacol Exp Ther (1998) 0.85
Drug-induced heat-shock preconditioning improves postischemic ventricular recovery after cardiopulmonary bypass. Circulation (1995) 0.85
Alpha-1 adrenergic receptor agonist-induced preconditioning in isolated working rat hearts. J Pharmacol Exp Ther (1995) 0.84
Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers. J Thorac Cardiovasc Surg (1986) 0.84
Retrograde continuous warm blood cardioplegia. Ann Thorac Surg (1991) 0.84
Late complications of intraoperative coronary artery perfusion. Circulation (1973) 0.83
Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury. J Thorac Cardiovasc Surg (1986) 0.83
Routine operative arteriography following vascular reconstruction. Surg Gynecol Obstet (1969) 0.83
Mycotic infections on prosthetic and homograft heart valves: report of the first case of endocarditis caused by Hormodendrum dermatitidis. Ann Surg (1971) 0.83
Disseminated intravascular coagulation following extracorporeal circulation. J Thorac Cardiovasc Surg (1972) 0.83
The role of protein kinase in C ischemic/reperfused preconditioned isolated rat hearts. J Cardiovasc Pharmacol (1996) 0.83
Relative importance of nervous control of cardiac output and arterial pressure. Am J Cardiol (1971) 0.83
Aberrant right subclavian artery aneurysm: a rare cause of a superior mediastinal tumor. Chest (1972) 0.82
New technique for repair of posterior left ventricular rupture. J Thorac Cardiovasc Surg (1979) 0.82
Postnatal developmental profiles of antioxidant enzymes in heart. Ann N Y Acad Sci (1996) 0.82
Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol (1994) 0.82
Effect of normothermic blood cardioplegia on postoperative conduction abnormalities and supraventricular arrhythmias. Circulation (1992) 0.82
Enhanced phosphodiesteratic breakdown and turnover of phosphoinositides during reperfusion of ischemic rat heart. Circ Res (1988) 0.82
Rebound vasospasm after coronary revascularization in association with calcium antagonist withdrawal. Ann Thorac Surg (1984) 0.82
Polymorphonuclear leucocytes as potential source of free radicals in the ischaemic-reperfused myocardium. Eur Heart J (1990) 0.82
Developmental profiles of protective mechanisms of heart against peroxidative injury. Basic Res Cardiol (1987) 0.81
Signal transduction pathway leading to Hsp27 and Hsp70 gene expression during myocardial adaptation to stress. Ann N Y Acad Sci (1998) 0.81
Emergency cardiopulmonary bypass in the cardiac surgical unit can be a lifesaving measure in postoperative cardiac arrest. Circulation (1994) 0.81
Functional recovery of diabetic mouse hearts by glutaredoxin-1 gene therapy: role of Akt-FoxO-signaling network. Gene Ther (2010) 0.81
Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. J Pharmacol Exp Ther (1994) 0.81
Does the type of venous drainage or cardioplegia affect postoperative conduction and atrial arrhythmias? Circulation (1985) 0.81
Role of phospholipases A2 and C in myocardial ischemic reperfusion injury. Am J Physiol (1991) 0.81
Ginkgo biloba extract (EGb 761) improves postischemic function in isolated preconditioned working rat hearts. Coron Artery Dis (1994) 0.81
Myocardial injury associated with potassium arrest. Ann Thorac Surg (1976) 0.81
Nitric oxide signaling in ischemic heart. Cardiovasc Res (1995) 0.80
Oxygen-derived free radicals and hemolysis during open heart surgery. Mol Cell Biochem (1992) 0.79
The significance of coronary arterial stenosis during cardiopulmonary bypass. J Thorac Cardiovasc Surg (1975) 0.79
Preconditioning potentiates molecular signaling for myocardial adaptation to ischemia. Ann N Y Acad Sci (1996) 0.79
Metabolic enhancement of myocardial preservation during cardioplegic arrest. J Thorac Cardiovasc Surg (1986) 0.79
The time course of myocardial high-energy phosphate degradation during potassium cardioplegic arrest. Surgery (1979) 0.79
Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines. Biochem Pharmacol (1993) 0.79
Tricuspid annuloplasty. Five and one-half years' experience with 78 patients. J Thorac Cardiovasc Surg (1974) 0.79
Possible physiological role of myocardial fatty acid binding protein in phospholipid biosynthesis. J Lipid Mediat (1992) 0.79